Document Details
Form
Filing Date
Sep 24, 2021
Document Date
Sep 24, 2021
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
AN2 Therapeutics, Inc
Issuer
AN2 THERAPEUTICS, INC.
